The 2026 Immunotherapy for the Treatment of Renal Cell Carcinoma guideline, highlighting recommendations on diagnostic tests, immunotherapy, patient education, and more.  

• Immunotherapy for the Treatment of Renal Cell Carcinoma

• Society for Immunotherapy of Cancer

• March 23, 2026

• Guideline Summary: https://www.guidelinecentral.com/guideline/12674/

• Full-Text:  https://jitc.bmj.com/content/14/3/e013788

The 2026 Cancer in Pregnancy guideline, highlighting recommendations on imaging, thromboprophylaxis, surgery, timing of chemotherapy, and more.

• Cancer in Pregnancy

• Society for Maternal-Fetal Medicine

• March 12, 2026

• Guideline Summary: https://www.guidelinecentral.com/guideline/5144899/

• Full-Text:  https://obgyn.onlinelibrary.wiley.com/doi/10.1002/pmf2.70221

The 2026 Diagnosis and Management of Severe Acquired Aplastic Anemia guideline, highlighting key updates across diagnostic testing, treatment, and medical management. 

• Diagnosis and Management of Severe Acquired Aplastic Anemia

• American Society of Hematology

• March 24, 2026

• Guideline Summary: https://www.guidelinecentral.com/guideline/5175319/

• Full-Text:  https://ashpublications.org/bloodadvances/article/doi/10.1182/bloodadvances.2025019051/567383/American-Society-of-Hematology-2026-Guidelines-for

The 2026 Society of Critical Care Medicine guideline on Care and Management of Pediatric and Neonatal Intensive Care Patients at the End of Life, highlighting key recommendations on advance care planning, palliative care education, disparities in care, and more

• Care and Management of Pediatric and Neonatal Intensive Care Patients at the End of Life

• Society of Critical Care Medicine

• March 20, 2026

• Guideline Summary: https://www.guidelinecentral.com/guideline/5144843/

• Full-Text:  https://journals.lww.com/pccmjournal/abstract/2026/04000/society_of_critical_care_medicine_2026_guidelines.13.aspx

The 2026 Society of Critical Care Medicine guideline on Caring for Older Adults in the ICU, highlighting key recommendations on geriatric care models, delirium prevention, and management considerations in critically ill older patients.

• Caring for Older Adults in the ICU

• Society of Critical Care Medicine

• March 20, 2026

• Guideline Summary: https://www.guidelinecentral.com/guideline/5144818/

• Full-Text:  https://journals.lww.com/ccmjournal/fulltext/9900/society_of_critical_care_medicine_guidelines_on.785.aspx

The 2026 Society for Vascular Surgery guideline on Management of Blunt Thoracic Aortic Injury, covering key recommendations on nonoperative management, imaging, and more.

• Management of Blunt Thoracic Aortic Injury

• Society for Vascular Surgery

• March 24th, 2026

• Guideline Summary: https://www.guidelinecentral.com/guideline/5153399/

• Full-Text:  https://www.jvascsurg.org/article/S0741-5214(26)00110-2/fulltext

The 2026 American Venous Forum guideline on Care of Patients with Upper Extremity Deep Venous Thrombosis, highlighting key recommendations on gradeification, epidemiology, risk factors, diagnosis, prophylaxis, and treatment.

• Care of Patients with Upper Extremity Deep Venous Thrombosis

• American Venous Forum

• March 2, 2026

• Guideline Summary: https://www.guidelinecentral.com/guideline/5139916/

• Full-Text:  https://www.jvsvenous.org/article/S2213-333X(26)00021-1/fulltext

The 2026 Early Detection of Oral Squamous Cell Carcinoma and Potentially Malignant Disorders guideline, covering recommendations on cytology adjuncts, biopsy decisions, and clinical examination best practices.

• Early Detection of Oral Squamous Cell Carcinoma and Potentially Malignant Disorders

• American Dental Association

• March 3, 2026

• Guideline Summary: https://www.guidelinecentral.com/guideline/5131573/

• Full-Text:  https://jada.ada.org/article/S0002-8177(26)00037-1/fulltext

The 2026 EULAR guideline on Management of Rheumatoid Arthritis with Synthetic and Biologic Disease-Modifying Antirheumatic Drugs, summarizing key recommendations on DMARD therapy, treatment targets, and more.

• Management of Rheumatoid Arthritis with Synthetic and Biologic Disease-Modifying Antirheumatic Drugs

• European League Against Rheumatism (EULAR)

• March 13 2026

• Guideline Summary: https://www.guidelinecentral.com/guideline/5135295

• Full-Text:  https://ard.eular.org/article/S0003-4967(26)00075-0/fulltext

The 2026 AACE consensus statement on Algorithm for Management of Adults With Type 2 Diabetes, including a new classification algorithm and updated guidance.

• Algorithm for Management of Adults With Type 2 Diabetes – 2026 Update

• American Association of Clinical Endocrinologists

• March 3, 2026

• Guideline Summary: https://www.guidelinecentral.com/guideline/5139655/

• Full-Text: https://www.endocrinepractice.org/article/S1530-891X(26)00022-4/fulltext#author-abstract